BEST UNLIMITED TURBO LONG CERTIFICATE - ABBOTT LABORATORIES Stock

Certificat

AE61S

DE000SH7EQ92

Market Closed - Euronext Paris 12:30:00 2024-07-16 EDT
4.071 EUR +0.74% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - ABBOTT LABORATORIES
Current month-8.10%
1 month-6.03%
Date Price Change
24-07-16 4.071 +0.74%
24-07-15 4.041 -4.74%
24-07-12 4.242 -0.35%
24-07-11 4.257 +10.40%
24-07-10 3.856 +5.56%

Real-time Euronext Paris

Last update July 16, 2024 at 12:30 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
AE61S
ISINDE000SH7EQ92
Date issued 2022-03-15
Strike 81.41 $
Maturity Unlimited
Parity 5 : 1
Emission price 8.45
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.31
Lowest since issue 2.723

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
103 USD
Average target price
124.8 USD
Spread / Average Target
+21.20%
Consensus
  1. Stock Market
  2. Certificates
  3. AE61S Certificat